Novartis CEO, Joe Jimenez told Reuters the company is developing a new prototype of the ’smart‘ lens for accommodative vision correction that can be used by individuals with age-related vision problems.
“This project is progressing well. I had said it would take about five years to see a product on the market. The calendar is on track and we are already developing a technological lens prototype that should be tested on humans in 2016,” said Jimenez.
Last year when the two companies announced their partnership, they said they were developing two different ‘smart’ lenses, one to correct vision and the other to monitor blood sugar levels.
The ‘smart’ lens for those with presbyopia consists of miniaturized sensors and microchips that restore the eye’s natural ability to autofocus on nearby objects through accommodative vision correction. This technology could eliminate the need for glasses when reading or looking at other nearby objects.
The ‘smart’ contact lens designed to help diabetic patients monitor their glucose levels contains a small device made of non-invasive glucose sensors that measures glucose levels in the wearer’s tears. The data is transmitted wirelessly to a mobile device.
Since announcing the new holding company Alphabet, Google joined forces with pharmaceutical giant Sanofi to improve outcomes in people with diabetes. In August 2015, it announced collaboration with a leading continuous glucose-monitoring company DexCom, to develop smaller, better devices for people with diabetes.